Associations of Preoperative Irisin Levels of Paired Cerebrospinal Fluid and Plasma with Physical Dysfunction and Muscle Wasting Severity in Residents of Surgery Wards
Overview
Nutritional Sciences
Affiliations
Background: Myokine Irisin has been proposed to regulate metabolic homeostasis, which is related to chronic diseases or physical activity. However, whether irisin levels in paired cerebrospinal fruid (CSF), plasma and their ratio of inpatients, could use as biomarkers, and be independently related to the varying physical dysfunction, muscle wasting severity and chronic diseases with varying severe degrees, remain largely elusive.
Methods: We conducted an observational study to assess the independent associations between irisin levels in paired cerebrospinal fruid (CSF), plasma and their ratio, and the independence in activities of daily life (ADLs), muscle wasting severity and chronic diseases with varying severe degrees among elderly Chinese in-patient subjects.
Results: Among 217 inpatients in surgery wards with a mean age of 68.07 years (±15.94years), 31.3% of women and 68.7% of men were included in the study. Bivariate correlation analysis showed that Log transformed CSF and plasma irisin levels and their ratio were potential associated with age, fat%, muscle wasting time, ADLs, number of multimorbidity, the severity of bone mass loss and anemia. Regression models analysis indicated that CSF and plasma irisin levels and their ratio in inpatient individuals were independently associated with the independence in ADLs. Plasma irisin levels were independently related to the change of muscle wasting use.
Conclusions: Collectively, the evaluation of paired plasma and CSF irisin levels, and their ratio in in-patient individuals is intriguing candidates for the susceptibility of the independence in ADLs. Plasma irisin levels were positively associated with indepedence in ADLs, negatively related to muscle wasting severity, and could use as biomarkers for muscle wasting severity.
Abdulghani A, Poghosyan M, Mehren A, Philipsen A, Anderzhanova E Front Mol Neurosci. 2023; 15:997054.
PMID: 36776770 PMC: 9909442. DOI: 10.3389/fnmol.2022.997054.
Vanhorebeek I, Gunst J, Casaer M, Derese I, Derde S, Pauwels L J Endocr Soc. 2023; 7(3):bvad001.
PMID: 36726836 PMC: 9879715. DOI: 10.1210/jendso/bvad001.
The Role of Irisin in Exercise-Mediated Bone Health.
Liu L, Guo J, Chen X, Tong X, Xu J, Zou J Front Cell Dev Biol. 2021; 9:668759.
PMID: 34017836 PMC: 8129548. DOI: 10.3389/fcell.2021.668759.
Ruan Q, Chen J, Zhang R, Zhang W, Ruan J, Zhang M Front Psychol. 2021; 11:617610.
PMID: 33664689 PMC: 7921692. DOI: 10.3389/fpsyg.2020.617610.